ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹21 Cr | ₹22 Cr | ₹25 Cr | ₹13 Cr | ₹11 Cr |
What is the latest Total Debt ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹21 Cr |
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹11 Cr |
How is Total Debt of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹21 Cr | -4.68 | |
| Mar2025 | ₹22 Cr | -14.24 | |
| Mar2024 | ₹25 Cr | 89.68 | |
| Mar2023 | ₹13 Cr | 21.01 | |
| Mar2022 | ₹11 Cr | - | |
Compare Total Debt of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹2,945.0 Cr | 4.9% | -6.9% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 4.9% |
-6.9% |
-13.7% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses